'For patients I see in clinic, retatrutide may potentially be a highly impactful future tool to treat their obesity and transform their health trajectory.' The types of adverse events seen were generally consistent with trials of other weight-loss jabs, including nausea, diarrhoea, constipation and vomiting
It works by regulating blood sugar and appetite and is, therefore, used in diabetic patients for the management of the condition
When combined, Semax and Selank create a complementary dual-axis research blend for exploring cognition- and stress-related neurobiology
These consultations provide opportunities to review dietary habits, physical activity levels, medication adherence, and any barriers to success
Gastrointestinal side effects are the most commonly reported adverse events associated with retatrutide in clinical trials, consistent with the broader class of incretin-based therapies
Dietary Habits and Caloric Deficit The medication reduces appetite, but food choices still matter